Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to Gram-negative bacteria

Autor: Pilar Retamar, Patricia Fernández-Riejos, Álvaro Pascual, Marina de Cueto, Isabel Fernández Morales, Belén Gutiérrez-Gutiérrez, Jesús Rodríguez-Baño, Salvador Pérez-Galera
Přispěvatelé: Instituto de Salud Carlos III, European Commission, Red Española de Investigación en Patología Infecciosa
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Organ Dysfunction Scores
Clinical stability
Bacteremia
Logistic regression
Gastroenterology
Procalcitonin
0302 clinical medicine
SOFA
Blood culture
030212 general & internal medicine
Prospective Studies
Gram-negative bloodstream infections
Prospective cohort study
biology
medicine.diagnostic_test
Confounding
General Medicine
Middle Aged
Prognosis
Infectious Diseases
C-Reactive Protein
SOFA score
Female
hormones
hormone substitutes
and hormone antagonists

Microbiology (medical)
medicine.medical_specialty
030106 microbiology
C-reactive protein
03 medical and health sciences
Internal medicine
Sepsis
parasitic diseases
Gram-Negative Bacteria
medicine
Humans
Aged
business.industry
Predictors
bacterial infections and mycoses
medicine.disease
Kinetics
ROC Curve
biology.protein
business
Sepsis management
Biomarkers
Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
instname
Popis: [Objective] To investigate whether the magnitude of the change in procalcitonin (PCT) and C-reactive protein (CRP) levels between day 1 and day 2 after the blood culture date is associated with early clinical stability (ECS) on day 3 in patients with bacteremia due to Gram-negative bacteria (GNB).
[Materials/methods] A prospective cohort study carried out in a 950-bed tertiary hospital in Spain between March 2013 and May 2014. Patients with GNB bacteremia were included. Changes in PCT and CRP kinetics from day 1 to day 2 (∆%PCT, ∆%CRP) were expressed as percentage of decline in blood levels. Logistic regression was used to identify predictors of ECS. Classification and regression tree analysis was performed to identify breakpoints. The discriminatory power of ∆%CRP and ∆%PCT as predictors of ECS was assessed by the area under the ROC (AUROC).
[Results] 71 patients were included, and 53 (74.56%) reached ECS. Multivariate analyses showed that SOFA score on day 1, ∆%PCT, and ∆%CRP were associated with ECS after controlling for confounders. ∆%PCT ≥ 30% (decline) and ∆%CRP ≥ 10% (decline) predicted ECS only among patients with SOFA≤3 on day 1 (n = 54; 43 reached ECS). In these patients, the AUROCs for the prediction of ECS were 0.96 (95% CI: 0.90–1) for ∆%CRP and 0.96 (95% CI: 0.90–1) for ∆%PCT, respectively.
[Conclusions] In the subgroup of patients with a SOFA score on day 1 ≤3, a ≥30% decline in PCT or a ≥10% decline in CRP between day 1 and day 2 was a very good predictor of ECS (which in turn was associated with a lower 30-day mortality and a greater clinical cure on day 14). Patients who do not achieve this decrease may need more intensive workup. In this subgroup (with a SOFA on day 1 ≤3), CRP may be preferred due to its lower cost.
This study was supported by Plan Nacional de I + D + i 2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (RD16/0016/0008) and co-financed by the European Development Regional Fund “A way to achieve Europe”, Operative Program Intelligent Growth 2014–2020.
Databáze: OpenAIRE